Monday 8 June 2026

One To Watch

Alvine Pharmaceuticals


Want to Update your Company's Profile?


Latest Alvine Pharmaceuticals News

ImmunogenX buys Alvine Pharma assets, including latiglutenase
7 February 2020
New chief medical officer at food allergy company Aimmune
23 June 2016
New drugs could drive celiac disease market to over $550 million by 2023, says analyst
31 October 2014
AbbVie and Alvine link up on investigational oral therapy for celiac disease
15 May 2013
More Alvine Pharmaceuticals news >


Today's issue

Scottish biotech Bead BioPharma emerges from stealth with ADC platform
Biotechnology
Scottish biotech Bead BioPharma emerges from stealth with ADC platform
8 June 2026
Biotechnology
FDA approves new indication for Pfizer’s Hympavzi
8 June 2026
Pharmaceutical
AdvanCell strengthens executive leadership
8 June 2026
Biotechnology
Sanofi expands AI ambitions through new Owkin collaboration
8 June 2026
Pharmaceutical
MannKind highlights wider role for Afrezza at ADA 2026
8 June 2026
Pharmaceutical
A missing perspective: the burden of skin disease in women
8 June 2026
Biotechnology
Engitix inks collaboration with GSK for liver fibrosis drugs
8 June 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze